Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation

American Journal of Cardiology

Volumn 94, Issue 12, 2004, Pages 1563-1566

  Kochiadakis, George E ^a   Igoumenidis, Nikos E ^a   Hamilos, Michail E ^a   Tzerakis, Panagiotis G ^a   Klapsinos, Nikos C ^a   Chlouverakis, Gregory I ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROPAFENONE; SOTALOL; ANTIARRHYTHMIC AGENT;

ADULT; AGED; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; ECG ABNORMALITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LIVER DYSFUNCTION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; SINUS RHYTHM; TASTE DISORDER; COMPARATIVE STUDY; MIDDLE AGED; RECURRENT DISEASE; SAFETY;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPAFENONE; PROSPECTIVE STUDIES; RECURRENCE; SAFETY; SOTALOL;

EID: 13944252558     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.08.041     Document Type: Article

References (20)

1. G.E. Kochiadakis, N.E. Igoumenidis, M.I. Hamilos, P.G. Tzerakis, N.C. Klapsinos, E.A. Zacharis, P.E. Vardas Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses Chest 125 2004 377 383
2. G.E. Kochiadakis, M.E. Marketou, N.E. Igoumenidis, S.I. Chrysostomakis, H.E. Mavrakis, M.D. Kaleboubas, P.E. Vardas Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? Pacing Clin Electrophysiol 23 11 pt 2 2000 1883 1887
3. J.G. Porterfield, L.M. Porterfield Therapeutic efficacy and safety of oral propafenone for atrial fibrillation Am J Cardiol 63 1989 114 116
4. M. Chimienti, M.T. Cullen Jr, G. Casadei Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias Report from the Flecainide and Propafenone Italian Study (FAPIS) Group Eur Heart J 16 1995 1943 1951
5. E.M. Antman, A.D. Beamer, C. Cantillon, N. McGowan, P.L. Friedman Therapy of refractory symptomatic atrial fibrillation and atrial flutter A staged care approach with new antiarrhythmic drugs J Am Coll Cardiol 15 1990 698 707
6. S. Juul-Moller, N. Edvardsson, N. Rehnqvist-Ahlberg Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation Circulation 82 1990 1932 1939
7. D.G. Benditt, J.H. Williams, J. Jin, T.F. Deering, R. Zucker, K. Browne, P. Chang-Sing, B.N. Singh for d,l-Sotalol Atrial Fibrillation/Flutter Study Group Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter Am J Cardiol 84 1999 270 277
8. M.R. Southworth, D. Zarembski, M. Viana, J. Bauman Comparison of sotalol versus quinidine for maintenance of normal sinus rhythm in patients with chronic atrial fibrillation Am J Cardiol 83 1999 1629 1632
9. G.E. Kochiadakis, N.E. Igoumenidis, M.E. Marketou, M.C. Solomou, E.M. Kanoupakis, P.E. Vardas Low dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation Am J Cardiol 81 1998 995 998
10. S.J. Connolly, D.L. Hoffert Usefulness of propafenone for recurrent paroxysmal atrial fibrillation Am J Cardiol 63 1989 817 819
11. C.R. Kerr, G.J. Klein, J.E. Axelson, J.C. Cooper Propafenone for prevention of recurrent atrial fibrillation Am J Cardiol 61 1988 914 916
12. S.C. Hammill, D.L. Wood, B.J. Gersh, M.J. Osborn, D.R. Holmes Jr Propafenone for paroxysmal atrial fibrillation Am J Cardiol 61 1988 473 474
13. R. Stroobandt, B. Stiels, R. Hoebrechts Propafenone Atrial Fibrillation Trial Investigators Propafenone for conversion and prophylaxis of atrial fibrillation Am J Cardiol 79 1997 418 423
14. UK Propafenone PSVT Study Group A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation Circulation 92 1995 2550 2557
15. A.P. Rae Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias Am J Cardiol 82 suppl 1998 59N 65N
16. D. Roy, M. Talajic, P. Dorian, S. Connolly, M.J. Eisenberg, M. Green, T. Kus, J. Lambert, M. Dubuc, P. Gagne Amiodarone to prevent recurrence of atrial fibrillation Canadian Trial of Atrial Fibrillation Investigators N Engl J Med 342 2000 913 920
17. E.L. Pritchett, R.L. Page, M. Carlson, K. Undesser, G. Fava Rythmol Atrial Fibrillation Trial (RAFT) Investigators Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation Am J Cardiol 92 2003 941 946
18. T. Meinertz, G.Y. Lip, F. Lombardi, Z.P. Sadowski, B. Kalsch, A. Camez, A. Hewkin, S. Eberle ERAFT Investigators Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (the European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT]Study) Am J Cardiol 90 2002 1300 1306
19. S.H. Lee, S.A. Chen, C.T. Tai, C.E. Chiang, Z.C. Wen, Y.J. Chen, W.C. Yu, J.L. Huang, A.N. Fong, J.J. Cheng, M.S. Chang Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation Am J Cardiol 79 1997 905 908
20. F. Bellandi, I. Simonetti, M. Leoncini, F. Frascarelli, T. Giovannini, M. Maioli, R.P. Dabizzi Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation Am J Cardiol 88 2001 640 645